SynthesisEuropean journal of clinical pharmacology2011

Risk of high-grade bleeding in patients with cancer treated with bevacizumab: a meta-analysis of randomized controlled trials.

Xiao Feng Hang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.